Nanocomposite sponges for enhancing intestinal residence time following oral administration

• Autor(a) principal: Rosso, Annalisa
• Data de Publicação: 2021
• Outros Autores: Andretto, Valentina, Chevalier, Yves, Kryza, David, Sidi-Boumedine, Jacqueline, Grenha, Ana, Guerreiro, Filipa, Gharsallaoui, Adem, La Padula, Veronica, Montembault, Alexandra, David, Laurent, Briançon, Stéphanie, Lollo, Giovanna
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.1/16685
• topic: Nanocomposite; Nanoemulsion; Chitosan sponge; Oral administration; Intestinal drug delivery

In this work, nanocomposites that combine mucopenetrating and mucoadhesive properties in a single system are proposed as innovative strategy to increase drug residence time in the intestine following oral administration. To this aim, novel mucoadhesive chitosan (CH) sponges loaded with mucopenetrating nanoemulsions (NE) were developed via freeze-casting technique. The NE mucopenetration ability was determined studying the surface affinity and thermodynamic binding of the nanosystem with mucins. The ability of nanoparticles to penetrate across a preformed mucins layer was validated by 3D-time laps Confocal Laser Scanning Microscopy imaging. Microscopy observations (Scanning Electron Microscopy and Optical Microscopy) showed that NE participated in the structure of the sponge affecting its stability and in vitro release kinetics. When incubated with HCT 116 and Caco-2 cell lines, the NE proved to be cytocompatible over a wide concentration range. Finally, the in vivo biodistribution of the nanocomposite was evaluated after oral gavage in healthy mice. The intestinal retention of NE was highly enhanced when loaded in the sponge compared to the NE suspension. Overall, our results demonstrated that the developed nanocomposite sponge is a promising system for sustained drug intestinal delivery.